BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38321899)

  • 1. Biodistribution and Tumor Targeted Accumulation of Anti-CEA-loaded Iron Nanoparticles.
    Correa TS; Lima WG; do Couto Campos AB; Galdino AS; de Oliveira Lima EC; Cardoso VN; Antunes Fernandes SO; Campos-da-Paz M
    Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38321899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CEA tagged iron nanoparticles for targeting triple-negative breast cancer.
    Correa TS; Bocca AL; Figueiredo F; Lima ECO; Almeida Santos MFM; Lacava ZGM; Campos-da-Paz M
    Biomed Mater; 2021 Mar; 16(3):. PubMed ID: 33540396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.
    da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG
    Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of Tumor Targeting and In Vivo Biodistribution of 
    El-Safoury DM; Ibrahim AB; El-Setouhy DA; Khowessah OM; Motaleb MA; Sakr TM
    J Pharm Sci; 2021 Aug; 110(8):2955-2965. PubMed ID: 33812886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
    Karacay H; McBride WJ; Griffiths GL; Sharkey RM; Barbet J; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 2000; 11(6):842-54. PubMed ID: 11087333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an anti-carcinoembryonic monoclonal antibody suitable for immunoscintigraphy.
    Moraes DW; Lima EN; Prado IB; Carneiro CR
    Braz J Med Biol Res; 1999 Aug; 32(8):967-74. PubMed ID: 10454758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.
    Orocio-Rodríguez E; Ferro-Flores G; Santos-Cuevas CL; Ramírez Fde M; Ocampo-García BE; Azorín-Vega E; Sánchez-García FM
    J Nanosci Nanotechnol; 2015 Jun; 15(6):4159-69. PubMed ID: 26369025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors.
    Tassano M; Camacho X; Freire T; Perroni C; da Costa V; Cabrera M; García MF; Fernandez M; Gambini JP; Cabral P; Osinaga E
    Cancer Biother Radiopharm; 2024 Jan; ():. PubMed ID: 38215243
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66.
    Esteban J; Raubitschek A; Felder B; Williams L; Wong J; Shively J
    Oncol Rep; 1995 Mar; 2(2):237-42. PubMed ID: 21597719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma.
    Leitha T; Walter R; Schlick W; Dudczak R
    Chest; 1991 Jan; 99(1):14-9. PubMed ID: 1984945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
    Yilmaz S; Ichedef C; Karatay KB; Teksöz S
    Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
    Pietersz GA; Patrick MR; Chester KA
    J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
    Szalai G; Williams LE; Primus FJ
    Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
    Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled Human Serum Albumin Nanoparticles Co-Loaded with Methotrexate and Decorated with Trastuzumab for Breast Cancer Diagnosis.
    Ekinci M; Alencar LMR; Lopes AM; Santos-Oliveira R; İlem-Özdemir D
    J Funct Biomater; 2023 Sep; 14(9):. PubMed ID: 37754891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
    Fernandes RS; Silva Jde O; Lopes SC; Chondrogiannis S; Rubello D; Cardoso VN; Oliveira MC; Ferreira LA; de Barros AL
    Nucl Med Commun; 2016 Mar; 37(3):307-12. PubMed ID: 26619397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.